MANJU FRANKLIN: Open Payments
NPI 1811517576 · DESPLAINES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 49 payments from 9 companies in 2025. Trend: 2023 $309 · 2024 $447 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $235 |
| ABBVIE INC. | 8 | $218 |
| Axsome Therapeutics, Inc. | 4 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $168 |
| Otsuka America Pharmaceutical, Inc. | 2 | $134 |
| Janssen Pharmaceuticals, Inc | 6 | $112 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Lundbeck LLC | 2 | $36 |
| Luye Pharma (USA) Ltd. | 1 | $26 |
Products named: VRAYLAR, Auvelity, AUSTEDO XR, REXULTI, CAPLYTA, INVEGA SUSTENNA, COBENFY, UZEDY.
Industry payments across IL — which companies pay providers there.
